Get 20% lifetime commission for referring investors to digrin.com
here.
Voyager Therapeutics, Inc. ( VYGR) - Stock Earnings
VYGR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
VYGR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -27.4 million USD | 15.3 million USD |
| 2026Q1 | -27.9 million USD | 2.6 million USD |
| 2026Q2 | -24.5 million USD | 3.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VYGR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 132.3 million USD | 250.0 million USD |
| 2024 | -65.0 million USD | 80.0 million USD |
| 2025 | -119.7 million USD | 40.4 million USD |
| 2026 Est. | — | — |
VYGR
Price: $1.90
52 week price:
Earnings Per Share: -1.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275000
Ebitda: -22.9 millionMarket Capitalization: 148.6 million